Eli Lilly Buys Osteoporosis Drug Patch for $35M


Eli Lilly Buys Osteoporosis Drug Patch for $35M 

Eli Lilly & Co. on Thursday said it will buy a midstage osteoporosis drug patch from Israeli specialty pharmaceutical company TransPharma Medical Ltd. for $35 million.
Boston Globe/AP
June 12

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

Accunet
Building a Scalable Big Data Infrastructure for Dynamic Workflows
Sponsored by Accunet


Sapio Sciences logo
Laboratory Management for Clinical and Research NGS Labs
Sponsored by Sapio Sciences, LLC


Computype
Fast and Accurate Sample ID in the Lab
Sponsored by Computype


Life Science Webcasts & Podcasts

Waters
Analog to Digital (A/D) Converters.  What are they and what is their role in data integrity?
Sponsored by Waters

Analog to Digital (A/D) converters are commonplace in many analytical labs.  Join this session to learn how these devices work and the important role they can play in data quality and integrity.

Listen Now 


More Podcasts

Job Openings

Sponsored Links

For reprints and/or copyright permission, please contact  Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com.